Novartis Sp ADR (NVS)

$105.00 0.85 (0.81%)

20:00 EDT NVS Stock Quote Delayed 30 Minutes

3 Stocks That Could Rocket on Biden’s Cancer Moonshot

By Will Ashworth, InvestorPlace Contributor Sep 20, 2022

Joe Biden’s cancer moonshot gave some of the drug companies a big shot in the arm. These three stocks all are doing big things in oncology.

6 Dividend Stocks With High Yields and Low P/E Ratios

3 Undervalued Stocks to Buy Before You Sell in May and Go Away

7 Drug Stocks to Consider After the Viatris Plunge

Volume:

Previous Close $112.26

Market Cap 209.06B

PE Ratio 17.89

EPS 5.87

Volume (Avg. Vol.) 3.52M

Day's Range $105.62 - $109.91

52-Week Range $89.08 - $116.64

Dividend & Yield $3.87 (3.69%)

NVS Stock Predictions, Articles, and Novartis Sp ADR News

7 Best Long-Term Stocks to Buy and Hold for the Next Decade

By Chris MacDonald, InvestorPlace Contributor Jan 13, 2022

These seven long-term stocks are among the best picks for truly long-term investors looking for companies to hold for the next decade.

AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today

By William White, InvestorPlace Writer Dec 2, 2021

Aurinia Pharma (AUPH) stock is on the rise Thursday as investors hold out hope for a takeover of the company by Novartis (NVS).

7 Drug Stocks to Buy Now While They’re Still on Sale

By Chris Lau, InvestorPlace Contributor Nov 30, 2021

Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.

7 Stocks to Buy That Will Make You Rich by 2030

By Chris Lau, InvestorPlace Contributor Nov 15, 2021

Patient investors who overcome short-term distractions will get a windfall with these stocks to buy, as they're set to grow at a faster pace.

7 Biotech Stocks Entering the Golden Boom Phase

By Chris Lau, InvestorPlace Contributor Sep 28, 2021

These biotech stocks offer a more mature take on an otherwise risky sector. These companies already have successes under their belt.

3 International Stocks to Buy for Dividend Growth

By Bob Ciura, Sure Dividend Sep 8, 2021

International stocks tend to offer higher yields than their U.S.-based counterparts, and also offer geographic diversification.

15 European Dividend Aristocrats to Diversify Your Portfolio

By Derek English Jul 21, 2021

Plenty of investors focus in on dividends, and dividend aristocrats, but if those investors only look in the U.S. they could be missing out.

7 Pharmaceutical Stocks With Dividends in Hand

By Thomas Niel, InvestorPlace Contributor Apr 28, 2021

So, which pharmaceutical stocks should be on your radar, if dividends are a top priority? Consider these seven compelling opportunities.

IMMP Stock: The Big Patent News Boosting Immutep Today

By Robert Lakin, InvestorPlace Contributor Apr 8, 2021

IMMP stock is getting a boost in Thursday trading after European regulators gave one of its cancer antibodies a key patent.

Midday Market Update: What Stocks Are Up Today?

By William White, InvestorPlace Writer Mar 12, 2021

The stock market has some major movers as noon rolls around on Friday and InvestorPlace is looking at what stocks are up today.

7 Pharmaceutical Stocks Working on Their Next Blockbuster

By Alex Sirois, InvestorPlace Contributor Mar 12, 2021

Pharmaceutical stocks are a sector with unique success factors. One factor is developing blockbuster drugs. These 7 are close.

NLSP Stock: The Big Deal News That Has NLS Pharma Rocketing Nearly 100% Today

By William White, InvestorPlace Writer Mar 12, 2021

NLS Pharma (NLSP) stock is taking off on Friday after announcing an exclusive license agreement with Novartis (NVS) for mazindol data.

The Top 7 Pharmaceutical Stocks for the Next 10 Years

By Alex Sirois, InvestorPlace Contributor Jan 11, 2021

Pharmaceutical stocks can be a great investment in a unique niche of the market. The stocks on this list will be strong for a decade plus.

Why Novartis’ Absence From the Covid-19 Vaccine Race Is a Benefit

By Josh Enomoto, InvestorPlace Contributor Sep 18, 2020

Although it’s one of the major pharmaceuticals, Novartis didn’t directly jump into the vaccine race. That might have been the best move for Novartis stock.

This Company is the Landlord of Life Sciences

By Neil George Aug 7, 2020

Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.

5 High-Yield Drug Stocks That Are Undervalued With Great Upside

By Mark R. Hake, CFA Jul 24, 2020

As the market continues to deal with the pandemic, these five cheap drug stocks have solid dividend yields of 4% and almost 37% upside.

This Stock Points to the Massive China Biotech Trend

By InvestorPlace Research Staff Apr 23, 2020

There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.

These 4 Stocks to Sell Are Melting Down Now

By William Roth, InvestorPlace Market Strategist Feb 26, 2020

These blue-chip names are stocks to sell now as the coronavirus continues its rapid spread around the world.

3 Great Healthcare Stocks to Buy Right Now

By David Moadel, InvestorPlace Contributor Jan 28, 2020

The sector is a safe bet for long-term growth, but which health-care stocks stand to gain the most? Here are three picks to consider today.

Stock Market Today: Merger Monday; Tesla’s Cybertruck Pre-Orders

By Bret Kenwell, InvestorPlace Contributor Nov 25, 2019

Tesla hit 200,000 pre-orders and there was a bevy of M&A to report. Here's what happened in the stock market today.

Novartis Sp ADR (NVS)

3 Stocks That Could Rocket on Biden’s Cancer Moonshot

6 Dividend Stocks With High Yields and Low P/E Ratios

3 Undervalued Stocks to Buy Before You Sell in May and Go Away

7 Drug Stocks to Consider After the Viatris Plunge

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Novartis Sp ADR (NVS)

NVS Stock Predictions, Articles, and Novartis Sp ADR News

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Subscriber Sign in